Hundreds of FDA Staff Remobilized for Inspection Activities

Following the FDA’s decision to expand its unpaid work to include inspection activities that are beyond “for-cause” inspections, Commissioner Scott Gottlieb announced that approximately 400 staff members will return to their posts, mostly for inspection-related tasks.

“About 400 total staff are being engaged in this mobilization,” Gottlieb said. “The vast majority are inspectors and others are professionals who work in support of inspectors.”

Of the staff being activated, around 70 will focus on inspections of high risk drug facilities, while approximately 90 will concentrate on inspecting high risk biological manufacturing facilities, he said.